Korro Bio Stock (NASDAQ:KRRO)
Previous Close
$6.41
52W Range
$5.70 - $56.69
50D Avg
$36.00
200D Avg
$22.85
Market Cap
$56.17M
Avg Vol (3M)
$474.16K
Beta
2.21
Div Yield
-
KRRO Company Profile
Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.